The 1 analysts offering 12-month price forecasts for Taro Pharmaceutical Industries Ltd have a median target of 35.00, with a high estimate of 35.00 and a low estimate of 35.00. The median estimate represents a -5.41% decrease from the last price of 37.00.
The current consensus among 1 polled investment analysts is to Buy stock in Taro Pharmaceutical Industries Ltd. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.32
Reporting Date Feb 07
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.